| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | -0.23 | 2e-12 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | 0.24 | 3e-12 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.26 | 5e-11 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.22 | 8e-11 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-10 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.2 | 3e-10 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | -0.21 | 3e-10 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.21 | 3e-10 |
| mRNA | OSI-027 | GDSC1000 | pan-cancer | AAC | -0.2 | 1e-09 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.21 | 1e-09 |